Pyramidal neuron loss and “glycine-site therapy”: A need for an animal model and study in late-life depression
- 1 September 1989
- journal article
- editorial
- Published by Elsevier in Neurobiology of Aging
- Vol. 10 (5), 616-618
- https://doi.org/10.1016/0197-4580(89)90152-8
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Tacrine, a Drug with Therapeutic Potential for Dementia: Post-Mortem Biochemical EvidenceCanadian Journal of Neurological Sciences, 1989
- Excitatory amino acids and Alzheimer's diseaseNeurobiology of Aging, 1989
- Reduced Glycine Stimulation of [3H]MK‐801 Binding in Alzheimer's DiseaseJournal of Neurochemistry, 1989
- Loss of glycine-dependent radioligand binding to the receptor complex in patients with Alzheimer's diseaseNeuroscience Letters, 1989
- Brain Protein Yields Clues to Alzheimer's DiseaseScience, 1989
- Clinical and Biochemical Manifestations of DepressionNew England Journal of Medicine, 1988
- N-methyl-d-aspartate (NMDA) receptors are inactivated by trypsinBrain Research, 1988
- Expression of the β-Nerve Growth Factor Gene in Hippocampal NeuronsScience, 1988
- Formation of the Neurotransmitter Glycine from the Anticonvulsant Milacemide Is Mediated by Brain Monoamine Oxidase BJournal of Neurochemistry, 1988
- Taking apart NMDA receptorsNature, 1987